Gossamer Bio
GOSS
GOSS
94 hedge funds and large institutions have $165M invested in Gossamer Bio in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 29 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
15% less funds holding
Funds holding: 110 → 94 (-16)
29% less capital invested
Capital invested by funds: $234M → $165M (-$68.8M)
58% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 26
Holders
94
Holding in Top 10
1
Calls
$591K
Puts
$576K
Top Buyers
| 1 | +$4.94M | |
| 2 | +$2.34M | |
| 3 | +$2.25M | |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$2.03M |
| 5 |
MAM
Monaco Asset Management
Monaco
|
+$1.96M |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$7.23M | |
| 3 | -$4.89M | |
| 4 |
Morgan Stanley
New York
|
-$3.73M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.34M |